Seminars in Radiation Oncology
Volume 16, Issue 4 , Pages 249-259, October 2006

Radiation Therapy With Charged Particles

  • Daniela Schulz-Ertner, MD

      Affiliations

    • Department of Radiation Oncology, University of Heidelberg, Germany.
  • ,
  • Oliver Jäkel, PhD

      Affiliations

    • Department of Medical Physics in Radiation Oncology, Deutsches Krebsforschungszentrum, Germany.
  • ,
  • Wolfgang Schlegel, PhD

      Affiliations

    • Department of Medical Physics in Radiation Oncology, Deutsches Krebsforschungszentrum, Germany.
    • Corresponding Author InformationAddress reprint requests to Wolfgang Schlegel, PhD, Deutsches Krebsforschungszentrum (dkfz), Abteilung Medizinische Physik in der Strahlentherapie (E040), Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany.

Charged particle beams can offer an improved dose conformation to the target volume as compared with photon radiotherapy, with better sparing of normal tissue structures close to the target. In addition, beams of ions heavier than 4He exhibit a strong increase of the linear energy transfer in the Bragg peak as compared with the entrance region. These physical and biological properties are much more favorable than in photon radiotherapy. As a consequence, particle therapy with protons and heavy ions has gained increasing interest worldwide, and many clinical centers are considering introducing radiation therapy with charged particles. This contribution summarizes the physical and technical principles of charged particle therapy with protons and heavy ions. It briefly reviews the clinical experience gathered so far with proton therapy and gives a more detailed summary of the recent results in carbon ion therapy of skull base tumors, head and neck tumors, non–small-cell lung cancer, hepatocellular carcinomas, bone and soft-tissue sarcomas, and prostate cancer.

Keywords:  ion therapy , proton therapy , carbon therapy , heavy ions , charged particle therapy , hadrons , 3D conformal radiotherapy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1053-4296(06)00034-8

doi:10.1016/j.semradonc.2006.04.008

Seminars in Radiation Oncology
Volume 16, Issue 4 , Pages 249-259, October 2006